Particularly, CBF/MYH11+ AML progenitors showed an almost exclusive immunophenotypic signature, as well as several characteristic LAIPs that were found in other molecular subtypes, such as KMT2A, PML-RARa and NPM1. This evidence concerns the gene KMT2A and acute myeloid leukemia.